亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China

医学 羟基氯喹 内科学 临床终点 随机对照试验 系统性红斑狼疮 疾病 传染病(医学专业) 2019年冠状病毒病(COVID-19)
作者
Yunyun Fei,Lidan Zhao,Lijun Wu,Xiaoxia Zuo,Rongli Li,Jiaomei Cheng,Hui Luo,Xue Wu,Li Yan Sun,Jingjing Xu,Yingxuan Zhu,Yang Wang,Zhu Chen,Xiaomei Li,Xiaofei Wang,Xuan Zhang
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:84 (2): 274-283 被引量:17
标识
DOI:10.1136/ard-2024-225826
摘要

Objectives

To explore the relapse rate after glucocorticoid (GC) withdrawal with or without hydroxychloroquine (HCQ) maintenance in sustained clinically inactive systemic lupus erythematosus (SLE).

Methods

The PRESS trial is a multicentre, 33-week, open-label, three-arm, non-inferiority designed, randomised controlled trial. SLE patients with sustained clinically inactive disease who were maintained on low-dose GC plus HCQ therapy were screened and qualified patients were randomly assigned to three groups: drug-free group (both GC and HCQ withdrawal); HCQ group (discontinued GC but maintained HCQ); dual maintenance group (both GC and HCQ continued). The primary endpoint was to compare the proportion of patients experiencing a relapse as defined by the Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index flare index by 33 weeks. Two parallel non-inferiority analyses were performed (drug-free group vs dual maintenance group and HCQ group vs dual maintenance group).

Results

From 3 November 2016 to 13 August 2021, 333 participants complied with the protocol after randomisation were analysed. The relapse rates in the three groups were 26.1%, 11.2% and 4.7%, respectively. Compared with dual maintenance group, drug-free group failed to achieve non-inferiority significance (relapse rate difference 21.4%; 95% CI 12.3% to 30.5%; Pnon-inferiority=0.238), whereas HCQ group achieved non-inferiority (relapse rate difference 6.5%; 95% CI −0.5% to 13.5%; Pnon-inferiority=0.034). HCQ group also exhibited fewer relapses than drug-free group (p=0.006). Adverse events were similar among all three groups.

Conclusions

GC withdrawal may be feasible in sustained clinically inactive SLE patients. HCQ maintenance can exert a protective role in preventing disease relapse after GC withdrawal.

Trial registration number

NCT02842814.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sugar发布了新的文献求助10
2秒前
6秒前
万能图书馆的应助被sugar采纳,获得10
8秒前
从容飞雪完成签到,获得积分10
20秒前
Owen的应助被海洋球采纳,获得10
22秒前
科研通AI65的应助被白丶魈白采纳,获得10
23秒前
36秒前
科研战士完成签到,获得积分10
41秒前
bai123完成签到,获得积分10
42秒前
清爽水之完成签到,获得积分10
47秒前
柠檬完成签到,获得积分10
49秒前
机灵发夹完成签到,获得积分10
53秒前
54秒前
54秒前
科研战士发布了新的文献求助10
55秒前
tinner完成签到,获得积分10
56秒前
1分钟前
海洋球发布了新的文献求助10
1分钟前
1分钟前
四氧化三铁完成签到,获得积分10
1分钟前
寒冷的映冬完成签到,获得积分10
1分钟前
郑糖糖糖完成签到 ,获得积分10
1分钟前
今后的应助被科研通管家采纳,获得10
1分钟前
sora98完成签到 ,获得积分0
1分钟前
latata完成签到 ,获得积分10
1分钟前
英姑的应助被北城采纳,获得10
1分钟前
郑糖糖完成签到 ,获得积分10
1分钟前
乐观寻芹完成签到,获得积分10
1分钟前
1分钟前
mm发布了新的文献求助10
1分钟前
null的应助被一期一会采纳,获得10
1分钟前
2分钟前
风趣的雨莲完成签到,获得积分10
2分钟前
Ankie完成签到,获得积分10
2分钟前
2分钟前
2分钟前
北城完成签到,获得积分10
2分钟前
北城发布了新的文献求助10
2分钟前
丰富的藏鸟完成签到,获得积分10
2分钟前
冷艳凡灵完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195075
求助须知:如何正确求助?哪些是违规求助? 9580886
关于积分的说明 21872780
捐赠科研通 7794957
什么是DOI,文献DOI怎么找? 3437922
关于科研通互助平台的介绍 2561217
邀请新用户注册赠送积分活动 2484584